Home LiteratureArticle Details
PMID: 1445258 Published · ppublish English Case Reports Journal Article Research Support, Non-U.S. Gov't

Characterization of three osteogenesis imperfecta collagen alpha 1(I) glycine to serine mutations demonstrating a position-dependent gradient of phenotypic severity.

The Biochemical journal ·Vol. 288 ( Pt 1) ·1992-11-15 ·Pages 131-5

Bateman JF, Moeller I, Hannagan M, Chan D, Cole WG

Abstract

Type I collagen alpha 1(I) glycine to serine substitutions, resulting from G-to-A mutations, were defined in three cases of osteogenesis imperfecta (OI). The Gly substitutions displayed a gradient of phenotypic severity according to the location of the mutation in the collagen triple helix. The most C-terminal of these, Gly565 to Ser, led to the lethal perinatal (type II) form of OI, whereas the more N-terminal mutations, Gly415 and Gly352 to Ser, led to severe OI (type III/IV) and moderate OI (type IVB) respectively. These data support the notion that glycine substitutions towards the C-terminus of the alpha 1(I) or alpha 2(I) chains will be more clinically severe than those towards the N-terminus. This results from the more disruptive effect of the mutations at the C-terminus on helix initiation and C- and N-terminal helix directional propagation. This generalization must be modified by considering the nature of the glycine substitution and the surrounding amino acid sequence, since the helix is composed of subdomains of differing stability which will affect the ability of helix re-nucleation and propagation.

MeSH Terms
Amino Acid Sequence Base Sequence Child Collagen/chemistry,genetics Female Glycine/genetics Hot Temperature Humans Infant Infant, Newborn Male Molecular Sequence Data Mutation Nucleic Acid Heteroduplexes Osteogenesis Imperfecta/genetics Phenotype Protein Denaturation RNA, Messenger/chemistry Serine/genetics
Chemicals
Nucleic Acid Heteroduplexes RNA, Messenger Serine Collagen Glycine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Bateman J F
Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Parkville, Victoria, Australia.
Moeller I
Hannagan M
Chan D
Cole W G
References (32)
32 references, click to expand
  1. Biological detection of specific mRNA molecules by microinjection.
    Proc Natl Acad Sci U S A. 1979 Sep;76(9):4503-6 PMID: 291982
  2. A type I collagen with substitution of a cysteine for glycine-748 in the alpha 1(I) chain copolymerizes with normal type I collagen and can generate fractallike structures.
    Biochemistry. 1991 May 21;30(20):5081-8 PMID: 2036375
  3. Brittle bones--fragile molecules: disorders of collagen gene structure and expression.
    Trends Genet. 1990 Sep;6(9):293-300 PMID: 2238087
  4. Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent.
    Am J Hum Genet. 1990 Jun;46(6):1034-40 PMID: 2339700
  5. Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-alpha 1(I) collagen gene.
    Nature. 1988 Mar 10;332(6160):131-6 PMID: 2450280
  6. Substitution of serine for alpha 1(I)-glycine 844 in a severe variant of osteogenesis imperfecta minimally destabilizes the triple helix of type I procollagen. The effects of glycine substitutions on thermal stability are either position of amino acid specific.
    J Biol Chem. 1989 Nov 25;264(33):19694-9 PMID: 2511192
  7. Mutations that substitute serine for glycine alpha 1-598 and glycine alpha 1-631 in type I procollagen. The effects on thermal unfolding of the triple helix are position-specific and demonstrate that the protein unfolds through a series of cooperative blocks.
    J Biol Chem. 1990 Aug 15;265(23):13995-4000 PMID: 2116413
  8. Improvement of PCR amplified DNA sequencing with the aid of detergents.
    Nucleic Acids Res. 1990 Mar 11;18(5):1309 PMID: 2320432
  9. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.
    Science. 1988 Jan 29;239(4839):487-91 PMID: 2448875
  10. Detection and localization of base changes in RNA using a chemical cleavage method.
    Anal Biochem. 1989 Dec;183(2):263-8 PMID: 2483035
  11. A frameshift mutation results in a truncated nonfunctional carboxyl-terminal pro alpha 1(I) propeptide of type I collagen in osteogenesis imperfecta.
    J Biol Chem. 1989 Jul 5;264(19):10960-4 PMID: 2500431
  12. Osteogenesis imperfecta type IV. Detection of a point mutation in one alpha 1(I) collagen allele (COL1A1) by RNA/RNA hybrid analysis.
    J Biol Chem. 1989 Jul 15;264(20):11893-900 PMID: 2745420
  13. Glycation induces expansion of the molecular packing of collagen.
    J Mol Biol. 1988 Sep 20;203(2):495-505 PMID: 3143838
  14. A substitution of cysteine for glycine 748 of the alpha 1 chain produces a kink at this site in the procollagen I molecule and an altered N-proteinase cleavage site over 225 nm away.
    J Biol Chem. 1988 Dec 15;263(35):19249-55 PMID: 3198624
  15. Biochemical heterogeneity of type I collagen mutations in osteogenesis imperfecta.
    Ann N Y Acad Sci. 1988;543:95-105 PMID: 3214058
  16. Comprehensive analysis of collagen metabolism in vitro using [4(3H)]/[14C]proline dual-labeling and polyacrylamide gel electrophoresis.
    Anal Biochem. 1988 Jan;168(1):171-5 PMID: 3364711
  17. Collagen defects in lethal perinatal osteogenesis imperfecta.
    Biochem J. 1986 Dec 15;240(3):699-708 PMID: 3827862
  18. Induction of metallothionein mRNA in rat liver and kidney after copper chloride injection.
    Biochem J. 1985 Jun 1;228(2):425-32 PMID: 4015627
  19. A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.
    Eur J Biochem. 1974 Jul 1;46(1):83-8 PMID: 4850204
  20. Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta.
    Biochem J. 1984 Jan 1;217(1):103-15 PMID: 6421277
  21. Proteolytic enzymes as probes for the triple-helical conformation of procollagen.
    Anal Biochem. 1981 Jan 15;110(2):360-8 PMID: 7015914
  22. Characterization of point mutations in the collagen COL1A1 and COL1A2 genes causing lethal perinatal osteogenesis imperfecta.
    J Biol Chem. 1989 Sep 25;264(27):15809-12 PMID: 2777764
  23. Structure of a full-length cDNA clone for the prepro alpha 1(I) chain of human type I procollagen.
    Biochem J. 1988 Aug 1;253(3):919-22 PMID: 3178743
  24. Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations.
    Proc Natl Acad Sci U S A. 1988 Jun;85(12):4397-401 PMID: 3260032
  25. An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. Application to hemophilia A.
    N Engl J Med. 1987 Oct 15;317(16):985-90 PMID: 3657865
  26. Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II.
    Nature. 1985 Jul 25-31;316(6026):363-6 PMID: 4022126
  27. Heritable diseases of collagen.
    N Engl J Med. 1984 Aug 9;311(6):376-86 PMID: 6146097
  28. Stability of proteins. Proteins which do not present a single cooperative system.
    Adv Protein Chem. 1982;35:1-104 PMID: 6762066
  29. Genetic heterogeneity in osteogenesis imperfecta.
    J Med Genet. 1979 Apr;16(2):101-16 PMID: 458828
  30. Osteogenesis imperfecta: translation of mutation to phenotype.
    J Med Genet. 1991 Jul;28(7):433-42 PMID: 1895312
  31. Sequence specific thermal stability of the collagen triple helix.
    Int J Biol Macromol. 1991 Jun;13(3):152-6 PMID: 1911555
  32. Mutations in collagen genes: causes of rare and some common diseases in humans.
    FASEB J. 1991 Apr;5(7):2052-60 PMID: 2010058
Article Info
Journal
The Biochemical journal
Abbr.
Biochem J
ISSN
0264-6021
Published
1992-11-15
Pages
131-5
Language
English
Region
England
NLM ID
2984726R
PMCID
PMC1132089
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com